A simple to initiate once-daily solution that breaks through the complexity of living with type 2 diabetes. Nominal therapy cost enables wider access to ... Apr 30
It is essential for all involved parties to adhere to these guidelines to prevent the introduction of sub-standard products into the market and uphold ... Apr 19
This innovative approach not only offers advanced therapeutic options to cancer patients but also addresses the affordability and accessibility challenges associated with life-saving treatments. ... Dec 06
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings .... Oct 31
Medical devices Manufacturers have a new guideline, The Central Drugs Standard Organization (CDSCO) issued a new deadline of October 1, for the categorized medical devices ... Oct 09
WHO (World Health Organization) made an alert on the manufacture of Made-in-India medicines such as cough syrups and vitamins that were linked to ... Jun 21
Dry AMD is the largest cause of incurable blindness in people above 60 and affects roughly 170 million people worldwide.The investment will allow Eyestem ... Aug 11
The investment will allow Eyestem to progress a treatment for Dry Age-related Macular Degeneration into clinical trials. ... Aug 08
CoviEasy has undergone stringent quality checks at the Indian Council of Medical Research (ICMR) approved validation centre and further received approval from the Drugs Controller ... Jun 17
... May 20
The Drugs Controller General of India (DCGI) has given BharatBiotech’s Covaxin restricted emergency use authorisation. This vaccine can now be used for children between ... Apr 26
PM Narendra Modi said that government will bear the cost of 3 crore vaccination for frontline workers... Jan 12
DGCI on Sunday (January 3) formally approved Serum Institute's Covishield and Bharat Biotech's Covaxin for use in India. ... Jan 04
Both the vaccines are cleared by DCGI... Jan 04
An expert panel today recommended granting permission for restricted emergency use authorisation for Bharat Biotech's indigenously developed COVID-19 vaccine — Covaxin. ... Jan 02
India has approved the COVID-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunization campaign in the world’s ... Jan 02
The Subject Expert Committee (SEC) in the Central Drugs Standard Control Organisation, CDSCO met yesterday to consider Emergency Use Authorization request from Pfizer, SII, and ... Dec 31
The pharma company is geared up by providing affordable, high quality, 'Made in India' 2-gene multiplex COVID-19 RT-PCR tests across the country... Nov 28
The MoU will help in establishing a framework for fruitful cooperation and exchange of information between the Central Drugs Standard Control Organization (CDSCO) and the ... Nov 04
The Bharat Biotech, which is into developing Covaxin - a vaccine candidate for COVID-19, on Friday said that it will now be conducting Phase III ... Oct 24
Problem for Dr Reddy as Indian Govt refuses Russian sputnik vaccine trial in the country... Oct 09
AiMeD unveils figure of growth rate of Indian Medical Device Industry during COVID-19 pandemic ... Oct 01
Serum Institute allowed to carry on final trials of the Oxford University vaccine... Aug 03
Hyderabad's Avra Labs to make Favipiravir for Cipla's Ciplenza ... Jul 28
PM Modi, will launch 3 new high-throughput labs of the Indian Council of Medical Research in Noida, Kolkata, and Mumbai on 27th July.... Jul 25
-Advertisements-
Tuesday, May 14, 2024
.jpeg)
